Actuate Therapeutics(us:ACTU)

    6.76

    -0.15%

    Updated on 2024-12-23

    Open:6.94
    Close:6.76
    High:7.10
    Low:6.27
    Pre Close:6.77
    Volume:80093.00
    Amount:542174.00
    Turnover:0.41%
    Shares:19.53M
    MarketCap:132.03M
    Total 2 records
    codechangetotalincreasedecreaserps5rps10rps15rps20

    Biote...

    BK2069

    		+0.60%67230535331142442

    Recen...

    BK2543

    		+0.70%41918613627233025

    About

    Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.
    Address:1751 River Run,Suite 400
    Website:

    Market Movers